IQV · XBRL financial data

Iqvia Holdings financial statements, every fiscal year

The same tables from 8 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (IQV's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	11,359	13,874	14,410	14,984	15,405	16,310
Selling, general and administrative	1,789	1,964	2,071	2,053	1,992	1,999
Operating income (loss)	731	1,393	1,799	1,977	2,202	2,182
Interest income	6	6	13	36	47	45
Interest expense	416	375	416	672	670	729
Other income (expense)	65	130	(33)	124	90	99
Income tax expense (benefit)	72	163	260	101	301	252
Net income (loss)	279	966	1,091	1,358	1,373	1,360
Earnings per share, basic USD per share	1.46	5.05	5.82	7.39	7.57	7.91
Earnings per share, diluted USD per share	1.43	4.95	5.72	7.29	7.49	7.84
Weighted average shares, basic millions of shares	191	191	188	184	181	172
Weighted average shares, diluted millions of shares	195	195	191	186	183	174

Fiscal years (IQV's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	1,814	1,366	1,216	1,376	1,702	1,980
Marketable securities	88	111	93	120	141	161
Total current assets	5,090	4,763	4,981	5,596	5,829	6,249
Property and equipment, net	482	497	532	523	535	533
Right-of-use asset	471	406	331	296	238	290
Goodwill	12,654	13,301	13,921	14,567	14,710	16,616
Total assets	24,564	24,689	25,337	26,681	26,899	29,944
Accrued liabilities	2,232	2,360	2,671	2,855	2,948	2,971
Current portion of long-term debt	149	91	152	718	1,145	1,840
Total current liabilities	4,558	5,241	5,578	6,491	6,957	8,338
Long-term debt	12,384	12,034	12,595	12,955	12,838	13,884
Lease liability, non-current	371	313	264	223	173	225
Total liabilities	18,284	18,647	19,572	20,569	20,832	23,314
Retained earnings	1,277	2,243	3,334	4,692	6,065	7,425
Total stockholders' equity	6,001	6,042	5,765	6,112	6,067	6,503
Total liabilities and equity	24,564	24,689	25,337	26,681	26,899	29,944
Common shares outstanding (cover page) millions of shares	191	190	186	182	176	170

Fiscal years (IQV's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	279	966	1,091	1,358	1,373	1,360
Stock-based compensation	95	170	194	217	206	247
Depreciation and amortization	1,287	1,264	1,130	1,125	1,114	1,144
Net cash from operating activities	1,959	2,942	2,260	2,149	2,716	2,654
Net cash from investing activities	(796)	(2,103)	(2,006)	(1,603)	(1,444)	(2,305)
Share repurchases	447	406	1,168	992	1,350	1,244
Net cash from financing activities	(217)	(1,235)	(329)	(382)	(878)	(150)
Net change in cash	977	(448)	(150)	160	326	278

SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Iqvia Holdings	2,249	4,428	825*	164.8M	Q3 FY26 10-QSep 30, 2026
Incyte	3,276	1,557	(675)*	203.8M	Q3 FY26 10-QSep 30, 2026
Charles River Laboratories International	200	983	254*	47.9M	Q3 FY26 10-QSep 26, 2026
Medpace Holdings	705	716	217*	28.0M	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 8, 2026, 6:22 AM ET. The filing on SEC.gov is the record.